Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 1, 2013, Pages 762-770

  Frankfort, Benjamin J ^a   Kareem Khan, A ^a   Tse, Dennis Y ^a   Chung, Inyoung ^a,b   Pang, Ji Jie ^a   Yang, Zhuo ^a   Gross, Ronald L ^a   Wu, Samuel M ^a  

^a CULLEN EYE INSTITUTE   (United States)

^b Gyeongsang National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; POLYSTYRENE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; ELECTRORETINOGRAM; EYE AXIS LENGTH; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA DISEASE; RETINA GANGLION CELL;

ANIMALS; AXIAL LENGTH, EYE; BIOLOGICAL MARKERS; BIOTIN; CELL COUNT; CELL DEATH; DARK ADAPTATION; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; OCULAR HYPERTENSION; RETINAL DISEASES; RETINAL GANGLION CELLS; TONOMETRY, OCULAR;

EID: 84874731366     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10581     Document Type: Article

References (54)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Arden GB, Jacobson JJ. A simple grating test for contrast sensitivity: preliminary results indicate value in screening for glaucoma. Invest Ophthalmol Vis Sci. 1978;17:23-32.
3. Henson DB, Artes PH, Chauhan BC. Diffuse loss of sensitivity in early glaucoma. Invest Ophthalmol Vis Sci. 1999;40:3147-3151.
4. Wilensky JT, Hawkins A. Comparison of contrast sensitivity, visual acuity, and Humphrey visual field testing in patients with glaucoma. Trans Am Ophthalmol Soc. 2001;99:213-217, discussion 217-218.
5. Anderson DR. Visual field loss in glaucoma. In: Anderson DR, ed. Perimetry with and without Automation. St. Louis: Mosby; 1987:142-159.
6. CNTGSG. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126:498-505.
7. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720, discussion 829-730.
8. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
9. Aihara M, Lindsey JD, Weinreb RN. Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci. 2003;44:4314-4320.
10. Gross RL, Ji J, Chang P, et al. A mouse model of elevated intraocular pressure: retina and optic nerve findings. Trans Am Ophthalmol Soc. 2003;101:163-169, discussion 169-171.
11. Grozdanic SD, Betts DM, Sakaguchi DS, Allbaugh RA, Kwon YH, Kardon RH. Laser-induced mouse model of chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2003;44:4337-4346.
12. Ji J, Chang P, Pennesi ME, et al. Effects of elevated intraocular pressure on mouse retinal ganglion cells. Vision Res. 2005;45: 169-179.
13. Ruiz-Ederra J, Verkman AS. Mouse model of sustained elevation in intraocular pressure produced by episcleral vein occlusion. Exp Eye Res. 2006;82:879-884.
14. Urcola JH, Hernandez M, Vecino E. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Exp Eye Res. 2006;83:429-437.
15. Chen H, Wei X, Cho KS, et al. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse. Invest Ophthalmol Vis Sci. 2011;52:36-44.
16. Cone FE, Gelman SE, Son JL, Pease ME, Quigley HA. Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection. Exp Eye Res. 2010;91:415-424.
17. Cone FE, Steinhart MR, Oglesby EN, Kalesnykas G, Pease ME, Quigley HA. The effects of anesthesia, mouse strain and age on intraocular pressure and an improved murine model of experimental glaucoma. Exp Eye Res. 2012;99C:27-35.
18. Samsel PA, Kisiswa L, Erichsen JT, Cross SD, Morgan JE. A novel method for the induction of experimental glaucoma using magnetic microspheres. Invest Ophthalmol Vis Sci. 2011;52:1671-1675.
19. Sappington RM, Carlson BJ, Crish SD, Calkins DJ. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci. 2010;51:207-216.
20. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A. 2010;107:5196-5201.
21. Bayer AU, Danias J, Brodie S, et al. Electroretinographic abnormalities in a rat glaucoma model with chronic elevated intraocular pressure. Exp Eye Res. 2001;72:667-677.
22. Ben-Shlomo G, Bakalash S, Lambrou GN, et al. Pattern electroretinography in a rat model of ocular hypertension: functional evidence for early detection of inner retinal damage. Exp Eye Res. 2005;81:340-349.
23. Bui BV, Edmunds B, Cioffi GA, Fortune B. The gradient of retinal functional changes during acute intraocular pressure elevation. Invest Ophthalmol Vis Sci. 2005;46:202-213.
24. Fortune B, Bui BV, Morrison JC, et al. Selective ganglion cell functional loss in rats with experimental glaucoma. Invest Ophthalmol Vis Sci. 2004;45:1854-1862.
25. Holcombe DJ, Lengefeld N, Gole GA, Barnett NL. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model. Br J Ophthalmol. 2008;92:683-688.
26. Mittag TW, Danias J, Pohorenec G, et al. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2000;41:3451-3459.
27. Moreno MC, Marcos HJ, Oscar Croxatto J, et al. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Exp Eye Res. 2005;81:71-80.
28. Grozdanic SD, Kwon YH, Sakaguchi DS, Kardon RH, Sonea IM. Functional evaluation of retina and optic nerve in the rat model of chronic ocular hypertension. Exp Eye Res. 2004;79: 75-83.
29. Abd-El-Barr MM, Pennesi ME, Saszik SM, et al. Genetic dissection of rod and cone pathways in the dark-adapted mouse retina. J Neurophysiol. 2009;102:1945-1955.
30. Moshiri A, Gonzalez E, Tagawa K, et al. Near complete loss of retinal ganglion cells in the math5/brn3b double knockout elicits severe reductions of other cell types during retinal development. Dev Biol. 2008;316:214-227.
31. Saszik SM, Robson JG, Frishman LJ. The scotopic threshold response of the dark-adapted electroretinogram of the mouse. J Physiol. 2002;543:899-916.
32. Pease ME, Cone FE, Gelman S, Son JL, Quigley HA. Calibration of the TonoLab tonometer in mice with spontaneous or experimental glaucoma. Invest Ophthalmol Vis Sci. 2011;52: 858-864.
33. Pang JJ, Wu SM. Morphology and immunoreactivity of retrogradely double-labeled ganglion cells in the mouse retina. Invest Ophthalmol Vis Sci. 2011;52:4886-4896.
34. Lyubarsky AL, Daniele LL, Pugh EN Jr. From candelas to photoisomerizations in the mouse eye by rhodopsin bleaching in situ and the light-rearing dependence of the major components of the mouse ERG. Vision Res. 2004;44:3235-3251.
35. Chou TH, Kocaoglu OP, Borja D, et al. Postnatal elongation of eye size in DBA/2J mice compared with C57BL/6J mice: in vivo analysis with whole-eye OCT. Invest Ophthalmol Vis Sci. 2011;52:3604-3612.
36. Dong CJ, Hare WA. Contribution to the kinetics and amplitude of the electroretinogram b-wave by third-order retinal neurons in the rabbit retina. Vision Res. 2000;40:579-589.
37. Kapousta-Bruneau NV. Opposite effects of GABA(A) and GABA(C) receptor antagonists on the b-wave of ERG recorded from the isolated rat retina. Vision Res. 2000;40:1653-1665.
38. Moller A, Eysteinsson T. Modulation of the components of the rat dark-adapted electroretinogram by the three subtypes of GABA receptors. Vis Neurosci. 2003;20:535-542.
39. Dijk F, van Leeuwen S, Kamphuis W. Differential effects of ischemia/reperfusion on amacrine cell subtype-specific transcript levels in the rat retina. Brain Res. 2004;1026:194-204.
40. Gunn DJ, Gole GA, Barnett NL. Specific amacrine cell changes in an induced mouse model of glaucoma. Clin Experiment Ophthalmol. 2011;39:555-563.
41. Kielczewski JL, Pease ME, Quigley HA. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci. 2005;46:3188-3196.
42. Crooks J, Kolb H. Localization of GABA, glycine, glutamate and tyrosine hydroxylase in the human retina. J Comp Neurol. 1992;315:287-302.
43. Pang JJ, Gao F, Wu SM. Light-evoked excitatory and inhibitory synaptic inputs to ON and OFF alpha ganglion cells in the mouse retina. J Neurosci. 2003;23:6063-6073.
44. Pourcho RG, Owczarzak MT. Connectivity of glycine immunoreactive amacrine cells in the cat retina. J Comp Neurol. 1991;307:549-561.
45. Veruki ML, Hartveit E. AII (Rod) amacrine cells form a network of electrically coupled interneurons in the mammalian retina. Neuron. 2002;33:935-946.
46. Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS. Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology. 2009;116:1846-1853.
47. Nelson P, Aspinall P, O'Brien C. Patients' perception of visual impairment in glaucoma: a pilot study. Br J Ophthalmol. 1999; 83:546-552.
48. Lee BL, Gutierrez P, Gordon M, et al. The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol. 1998;116:861-866.
49. Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954-1965.
50. Chang B, Smith RS, Hawes NL, et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet. 1999;21:405-409.
51. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951-962.
52. Libby RT, Anderson MG, Pang IH, et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci. 2005;22:637-648.
53. Heiduschka P, Julien S, Schuettauf F, Schnichels S. Loss of retinal function in aged DBA/2J mice-new insights into retinal neurodegeneration. Exp Eye Res. 2010;91:779-783.
54. Schuettauf F, Rejdak R, Walski M, et al. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol. 2004;107:352-358.